Is Medtronic (MDT) Undervalued Following Its Permanent CPT Code Win?

Medtronic (MDT) just picked up an important regulatory win, with the American Medical Association granting permanent Category I CPT codes for its Altaviva tibial neuromodulation implant and Symplicity Spyral renal denervation system. Medtronic shares closed at US$87.97, with a 1-day share price return of 1.84% following this regulatory update. However, the 30-day share price return is down 6.58% and the year-to-date move is down 8.41%, while the 3-year total shareholder return of 29.18%...